Frank Osterroth
14Patents
4h-index
27Co-inventors
52Inventor score
Filing activity: Dec 23, 2008 → Jan 7, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9011864B2 | Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates | Chemistry; Metallurgy | 16 | Active |
| US10117932B2 | Uses of immunoconjugates targeting CD138 | Human Necessities | 7 | Active |
| US9289509B2 | Uses of immunoconjugates targeting CD138 | Performing Operations; Transporting | 6 | Active |
| US9221914B2 | Agents targeting CD138 and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US8956607B2 | Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE) | Chemistry; Metallurgy | 4 | Active |
| US9387261B2 | Immunoconjugates targeting CD138 and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US8852871B2 | Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) | Chemistry; Metallurgy | 2 | Active |
| US9334325B2 | Method for treating psoriasis | Chemistry; Metallurgy | 1 | Active |
| US9446146B2 | Methods and agents for improving targeting of CD138 expressing tumor cells | Chemistry; Metallurgy | 1 | Active |
| US9550831B2 | Method for treating psoriasis | Chemistry; Metallurgy | 0 | Active |
| US9605066B2 | Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE) | Chemistry; Metallurgy | 0 | Active |
| US9540436B2 | Use of antibodies for detection of IL-10 | Chemistry; Metallurgy | 0 | Active |
| US9995733B2 | Agents for treating disease | Physics | 0 | Active |
| US9512226B2 | Agent for treating disease | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.